{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T14:35:53Z","timestamp":1790174153312,"version":"4.1.0"},"reference-count":27,"publisher":"Cambridge University Press (CUP)","issue":"1","license":[{"start":{"date-parts":[[2018,1,10]],"date-time":"2018-01-10T00:00:00Z","timestamp":1515542400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Prehosp. Disaster med."],"published-print":{"date-parts":[[2018,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec id=\"S1049023X17007166_abs1\" sec-type=\"intro\"><jats:title>Introduction<\/jats:title><jats:p>The efficacy of oral cholera vaccines (OCVs) in laboratory conditions has been established, and the World Health Organization (WHO; Geneva, Switzerland) has recommended their preventative use in high-risk settings. The WHO recommendation has not been fully operationalized, nor has it been extended to apply to the reactive use of OCVs in real field epidemic conditions due to concerns about potential resource diversion, feasibility, cost, and acceptability. The purpose of this study is to assess and synthesize existing evidence of OCV effectiveness when used reactively in real field conditions.<\/jats:p><\/jats:sec><jats:sec id=\"S1049023X17007166_abs2\" sec-type=\"methods\"><jats:title>Methods<\/jats:title><jats:p>A systematic review and meta-analysis was conducted involving studies that investigated vaccine effectiveness when used as a reactive measure; that is, cases had reached epidemic threshold and a cholera epidemic was declared in real field epidemic conditions. OVID Medline (US National Library of Medicine, National Institutes of Health; Bethesda, Maryland USA), CINAHL (EBSCO Information Services; Ipswich, Massachusetts USA), and EMBASE (Elsevier; Amsterdam, Netherlands), along with grey literature, were systematically searched using pre-determined criteria. Two independent reviewers identified studies that met the selection criteria and data were extracted using validated tools. Pooled estimates were obtained using fixed effect models.<\/jats:p><\/jats:sec><jats:sec id=\"S1049023X17007166_abs3\" sec-type=\"results\"><jats:title>Results<\/jats:title><jats:p>Of the 347 articles that met the inclusion criteria, four studies were retrieved for meta-analysis (three were case-control studies and one was a case-cohort study) involving a total of 1,509 participants and comprising 175 cases and 1,334 case controls. The effectiveness of one or two doses of either Shanchol (Shantha Biotechnics; India) or ORC-Vax (Vabiotech; Vietnam) OCVs showed a combined vaccine effectiveness of 75% (95% CI, 61-84).<\/jats:p><\/jats:sec><jats:sec id=\"S1049023X17007166_abs4\" sec-type=\"conclusion\"><jats:title>Conclusion<\/jats:title><jats:p>A positive association was demonstrated between the reactive use of OCVs and protection against cholera. This supported the WHO recommendation to utilize OCVs reactively as an additional measure to the standard cholera epidemic response package.<\/jats:p><jats:p><jats:mixed-citation id=\"S1049023X17007166_ref1\" publication-type=\"other\"><jats:name name-style=\"western\"><jats:surname>Schwerdtle<\/jats:surname><jats:given-names>P<\/jats:given-names><\/jats:name>, <jats:name name-style=\"western\"><jats:surname>Onekon<\/jats:surname><jats:given-names>CK<\/jats:given-names><\/jats:name>, <jats:name name-style=\"western\"><jats:surname>Recoche<\/jats:surname><jats:given-names>K<\/jats:given-names><\/jats:name>. <jats:article-title>A quantitative systematic review and meta-analysis of the effectiveness of oral cholera vaccine as a reactive measure in cholera outbreaks<\/jats:article-title>. <jats:source>Prehosp Disaster Med<\/jats:source>. <jats:year>2018<\/jats:year>;<jats:volume>33<\/jats:volume>(<jats:issue>1<\/jats:issue>):<jats:fpage>2<\/jats:fpage>\u2013<jats:lpage>6<\/jats:lpage>.<\/jats:mixed-citation><\/jats:p><\/jats:sec>","DOI":"10.1017\/s1049023x17007166","type":"journal-article","created":{"date-parts":[[2018,1,10]],"date-time":"2018-01-10T07:52:44Z","timestamp":1515570764000},"page":"2-6","source":"Crossref","is-referenced-by-count":12,"title":["A Quantitative Systematic Review and Meta-Analysis of the Effectiveness of Oral Cholera Vaccine as a Reactive Measure in Cholera Outbreaks"],"prefix":"10.1017","volume":"33","author":[{"given":"Patricia","family":"Schwerdtle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Coretta-Kings","family":"Onekon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrina","family":"Recoche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"56","published-online":{"date-parts":[[2018,1,10]]},"reference":[{"key":"S1049023X17007166_ref22","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(16)30211-X"},{"key":"S1049023X17007166_ref4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1312680"},{"key":"S1049023X17007166_ref18","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(14)70368-7"},{"key":"S1049023X17007166_ref20","volume-title":"Joanna Briggs Institute Reviewers\u2019 Manual: 2016 Edition","year":"2016"},{"key":"S1049023X17007166_ref21","volume-title":"Epidemiology","author":"Buttner","year":"2011"},{"key":"S1049023X17007166_ref1","unstructured":"Schwerdtle P , Onekon CK , Recoche K . A quantitative systematic review and meta-analysis of the effectiveness of oral cholera vaccine as a reactive measure in cholera outbreaks."},{"key":"S1049023X17007166_ref19","unstructured":"The Joanna Briggs Institute. New JBI levels of evidence. 2014. http:\/\/joannabriggs.org\/assets\/docs\/approach\/JBI-Levels-of-evidence_2014.pdf. Accessed February 17, 2017."},{"key":"S1049023X17007166_ref17","unstructured":"OXFAM. Cholera Outbreak Guidelines. 2014. https:\/\/www.unicef.org\/cholera_toolkit\/Annexes\/Supporting_Resources\/Annex_6B\/OXFAM_Cholera_guidelines.pdf. Accessed February 17, 2017."},{"key":"S1049023X17007166_ref2","doi-asserted-by":"publisher","DOI":"10.4161\/hv.19083"},{"key":"S1049023X17007166_ref9","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2011.174"},{"key":"S1049023X17007166_ref16","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jit194"},{"key":"S1049023X17007166_ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2003.11.070"},{"key":"S1049023X17007166_ref12","unstructured":"World Health Organization. WHO technical working group on creation of an oral cholera vaccine stockpile: meeting report; Geneva, Switzerland: April 26-27, 2012."},{"key":"S1049023X17007166_ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.actatropica.2008.05.023"},{"key":"S1049023X17007166_ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2010.05.008"},{"key":"S1049023X17007166_ref7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0088139"},{"key":"S1049023X17007166_ref26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0001006"},{"key":"S1049023X17007166_ref11","unstructured":"World Health Organization. Cholera Fact sheet no. 107. 2015. http:\/\/www.who.int\/mediacentre\/factsheets\/fs107\/en\/. Accessed February 17, 2017."},{"key":"S1049023X17007166_ref13","unstructured":"CDC. Principles of Epidemiology in Public Health practice, Third Edition. An Introduction to Applied Epidemiology and Biostatistics. 2012. http:\/\/www.cdc.gov\/ophss\/csels\/dsepd\/SS1978\/Lesson1\/Section1.html. Accessed February 17, 2017."},{"key":"S1049023X17007166_ref3","doi-asserted-by":"publisher","DOI":"10.1086\/652404"},{"key":"S1049023X17007166_ref8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001512"},{"key":"S1049023X17007166_ref6","doi-asserted-by":"publisher","DOI":"10.3201\/eid1711.110822"},{"key":"S1049023X17007166_ref10","doi-asserted-by":"publisher","DOI":"10.2471\/BLT.11.093427"},{"key":"S1049023X17007166_ref15","first-page":"659","article-title":"Potential impact of reactive vaccination in controlling cholera outbreaks: an exploratory analysis using a Zimbabwean experience","volume":"101","author":"Kim","year":"2011","journal-title":"South African Medical Journal"},{"key":"S1049023X17007166_ref24","doi-asserted-by":"publisher","DOI":"10.1002\/9780470743386"},{"key":"S1049023X17007166_ref23","unstructured":"Cochrane Community, Review Manager (RevMan). http:\/\/community.cochrane.org\/editorial-and-publishing-policy-resource\/information-technology\/review-manager-revman. Accessed February 17, 2017."},{"key":"S1049023X17007166_ref27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0135676"}],"container-title":["Prehospital and Disaster Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S1049023X17007166","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,15]],"date-time":"2019-04-15T20:18:57Z","timestamp":1555359537000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S1049023X17007166\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,10]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S1049023X17007166"],"URL":"https:\/\/doi.org\/10.1017\/s1049023x17007166","relation":{},"ISSN":["1049-023X","1945-1938"],"issn-type":[{"value":"1049-023X","type":"print"},{"value":"1945-1938","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,10]]}}}